Dashboard
Manage Tickers

VNDAVanda Pharmaceuticals Inc.

Nasdaq vandapharma.com


$ 5.35 $ -0.01 (-0.19 %)    

Thursday, 22-Aug-2024 10:56:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.40 $ -1.77 (-0.37 %)
DIA $ 408.56 $ -1.88 (-0.46 %)
SPY $ 560.91 $ -1.50 (-0.27 %)
TLT $ 97.78 $ -0.43 (-0.44 %)
GLD $ 229.35 $ -0.92 (-0.4 %)
$ 5.4
$ 5.36
$ 5.35 x 100
$ 5.36 x 100
$ 5.35 - $ 5.36
$ 3.30 - $ 6.75
343,755
na
314.39M
$ 0.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-08-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 07-28-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-09-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-11-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-26-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-03-2019 03-31-2019 10-Q
23 02-19-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 05-02-2018 03-31-2018 10-Q
27 02-15-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-03-2017 03-31-2017 10-Q
31 02-17-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 02-12-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 07-31-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-13-2015 12-31-2014 10-K
40 10-27-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-maintains-overweight-on-vanda-pharma-raises-price-target-to-13
Cantor Fitzgerald Maintains Overweight on ...
08/01/2024 16:57:03

Cantor Fitzgerald analyst Charles Duncan maintains Vanda Pharma (NASDAQ:VNDA) with a Overweight and raises the price target ...

vanda-pharmaceuticals-reinstates-guidance-sees-fy24-total-revenues-180m-210m
Vanda Pharmaceuticals Reinstates Guidance;...
07/31/2024 20:52:28

vanda-pharma-q2-2024-gaap-eps-008-beats-021-estimate-sales-50474m-beat-47860m-estimate
Vanda Pharma Q2 2024 GAAP EPS $(0.08) Beat...
07/31/2024 20:28:46

Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.21) ...

cantor-fitzgerald-initiates-coverage-on-vanda-pharma-with-overweight-rating-announces-price-target-of-11
Cantor Fitzgerald Initiates Coverage On Va...
07/11/2024 11:27:49

Cantor Fitzgerald analyst Charles Duncan initiates coverage on Vanda Pharma (NASDAQ:VNDA) with a Overweight rating and annou...

Core News & Articles
US District Court For The District Of Dela...
07/01/2024 12:05:49

whats-going-on-with-vanda-pharmaceuticals-shares-today
What's Going On With Vanda Pharmaceuticals...
06/27/2024 16:10:59

Vanda Pharmaceuticals shares decline as Future Pak withdraws acquisition offer following Vanda's rejection and lack of resp...

future-pak-late-wednesday-announced-the-withdrawal-of-its-proposal-to-purchase-vanda-pharmaceuticals-inc
Future Pak Late Wednesday Announced The Wi...
06/27/2024 13:02:17

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

why-vuzix-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Vuzix Shares Are Trading Higher By Aro...
06/20/2024 12:22:52

vanda-pharmaceuticals-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Vanda Pharmaceuticals And Other Big Stocks...
06/20/2024 09:29:09

reported-wednesday-vanda-pharmaceuticals-rejects-unsolicited-takeover-bids-citing-undervaluation
Reported Wednesday, Vanda Pharmaceuticals ...
06/20/2024 05:49:34

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the Company's Board of Directors (the "Board"...

tesla-nvidia-john-wiley--sons-and-other-big-stocks-moving-higher-on-thursday
Tesla, Nvidia, John Wiley & Sons And Other...
06/13/2024 14:17:19

vanda-pharmaceuticals-receives-revised-unsolicited-acquisition-proposal-from-future-pak-for-850-900-per-share-in-cash-plus-contingent-value-rights-no-shareholder-action-required-at-this-time
Vanda Pharmaceuticals Receives Revised Uns...
06/13/2024 14:03:49

future-pak-increases-cash-portion-of-its-offer-for-vanda-pharmaceuticals-by-075-125-to-850-900-per-share
Future Pak Increases Cash Portion Of Its O...
06/13/2024 12:18:38

https://www.businesswire.com/news/home/20240613906873/en/https://www.businesswire.com/news/home/20240613906873/en/

sp-500-edges-lower-j-m-smucker-shares-surge-following-earnings-beat
S&P 500 Edges Lower; J. M. Smucker Shares ...
06/06/2024 18:45:57

why-g-iii-apparel-shares-are-trading-lower-by-13-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why G-III Apparel Shares Are Trading Lower...
06/06/2024 17:39:18

crude-oil-jumps-2-lululemon-posts-upbeat-earnings
Crude Oil Jumps 2%; Lululemon Posts Upbeat...
06/06/2024 16:22:51

vanda-pharmaceuticals-receives-another-takeover-proposal-considers-466m-deal
Vanda Pharmaceuticals Receives Another Tak...
06/06/2024 16:13:16

Cycle Pharmaceuticals wants to acquire Vanda Pharmaceuticals for $8 per share, or $466 million. Cycle focuses on rare neurologi...

vanda-pharmaceuticals-confirms-unsolicited-non-binding-acquisition-proposal-from-cycle-group-holdings-at-800-per-share-in-cash
Vanda Pharmaceuticals Confirms Unsolicited...
06/06/2024 13:25:08

correction-vanda-pharmaceuticals-shares-are-trading-higher
CORRECTION: Vanda Pharmaceuticals shares a...
06/06/2024 12:15:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION